Updates

Zotefoams - Big capex plans come to an end

September 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Latest H1 shows sales + 39% to £48.2m, with strong demand across most regions and markets. At constant currency, revenue was up 46% to £50.7m. H1 adjusted EBITA was £4.8m.The key question I had for chief executive David Stirling and finance director Gary McGrath was whether H2 is going to be able to match the record H2 last year, which had been boosted by £9m of foams for PPE and which is not repeating. Brokers are looking for H2 sales to come in at £51m vs £46m. But it seems that this isn’t too much of a concern as demand has generally spiked for both the commodity and high performance textile sides of its business.Overall Polyolefin Foams - the commodity foams side - gre ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

D4T4 Solutions

Gattaca

Zotefoams (April 2023)

Zotefoams (April 2022)

Zotefoams (March 2021)

Zotefoams (September 2020)

Zotefoams - New contract worth possibly 10% to sales (July 2020)

Zotefoams - New capacity eases bottleneck (May 2020)

Zotefoams (February 2018)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X